Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246

Phase: N/A Priority: Normal
NCT ID: NCT00907803 Org: User:
Start: 06/30/09 End: 01/31/10 Due: 01/31/11

Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00431951 Org: User:
Start: 02/28/07 End: 02/29/08 Due: 02/28/09

A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox

Phase: N/A Priority: Normal
NCT ID: NCT03972111 Org: User:
Start: 01/01/20 End: 09/30/24 Due: 09/30/25

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

Phase: N/A Priority: Normal
NCT ID: NCT04392739 Org: User:
Start: 07/19/19 End: 12/05/19 Due: 12/05/20

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

Phase: N/A Priority: Normal
NCT ID: NCT04957485 Org: User:
Start: 04/05/22 End: 01/01/26 Due: 01/01/27

Phase I Trial of an Investigational Small Pox Medication

Phase: N/A Priority: Normal
NCT ID: NCT00728689 Org: User:
Start: 08/31/08 End: 10/31/08 Due: 10/31/09

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Phase: N/A Priority: Normal
NCT ID: NCT04485039 Org: User:
Start: 06/08/22 End: 04/23/23 Due: 04/23/24

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

Phase: N/A Priority: Normal
NCT ID: NCT02474589 Org: User:
Start: 06/19/15 End: 08/24/16 Due: 08/24/17

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

Phase: N/A Priority: Normal
NCT ID: NCT04971109 Org: User:
Start: 03/29/22 End: 05/12/23 Due: 05/12/24